Community Pharmacy England News

- 14TH AUGUST 2024
- 0 COMMENTS
MHRA Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited)
Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited) Drug alert number: EL (24)A/37 Date issued: 14 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited) Company
Read more
- Community Pharmacy England News
- 13TH AUGUST 2024
- 0 COMMENTS
Celebrating South Asian Heritage Month 2024
Pharmacy Press This month we celebrate South Asian Heritage Month, a time to honor the cultural contributions of South Asian communities in England. At Community Pharmacy England, we recognise our colleagues’ diverse journeys and experiences in community pharmacy and their significant contributions to our sector. In honour of this and this year’s theme, “Free to
Read more
- Community Pharmacy England News
- 13TH AUGUST 2024
- 0 COMMENTS
Community Pharmacy England makes submission to NHS review
Community Pharmacy England has set out the value, challenges and opportunities for the sector in its submission to Lord Darzi’s review of the NHS. The independent investigation of NHS performance, commissioned by the Secretary of State for Health and Social Care, is examining the challenges facing the healthcare system ahead of the development of a
Read more
- Community Pharmacy England News
- 12TH AUGUST 2024
- 0 COMMENTS
MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited)
Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Drug alert number: EL (24)A/36 Date issued: 12 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Company name: Star Pharmaceuticals Limited Product name: Diflucan Oral
Read more
- Community Pharmacy England News
- 9TH AUGUST 2024
- 0 COMMENTS
Rivaroxaban tablets – changes to reimbursement from September 2024
Currently all branded and generically written prescriptions for Rivaroxaban tablets are reimbursed in line with NHS list prices of the brand originator Xarelto®. However, licensed generic Rivaroxaban tablets have been available in the market for several months following the patent expiry of Xarelto®. Consequently, selling prices of generic Rivaroxaban tablets have fallen sharply when compared
Read more
- Community Pharmacy England News
- 9TH AUGUST 2024
- 0 COMMENTS
Community Pharmacy England presents strategy to improve outlook for pharmacy
A recorded presentation on what lies ahead for community pharmacy – including Community Pharmacy England’s strategy to improve the outlook for pharmacy owners and their teams – is now available to watch on-demand. Spring 2024 saw two key moments for community pharmacy: the end of the five-year CPCF and a General Election campaign. As critical
Read more
- Community Pharmacy England News
- 9TH AUGUST 2024
- 0 COMMENTS
Share your opinions on Pharmacy First thresholds: Pharmacy Owner Views Sought
Community pharmacy owners are being asked to share information and views about increasing Pharmacy First thresholds, as well as the impact of GP action, ahead of the next full Community Pharmacy England Committee meeting in September. Many pharmacies may struggle to meet scheduled increases in the threshold for the monthly Pharmacy First payment and pharmacy
Read more
- Community Pharmacy England News
- 8TH AUGUST 2024
- 0 COMMENTS
MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd)
Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Drug alert number: EL (24)A/35 MDR number: MDR 113-05/24 Date issued: 08 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Company name: Accord-UK Ltd Product name: Trandolapril 0.5mg
Read more
- Community Pharmacy England News
- 7TH AUGUST 2024
- 0 COMMENTS
Latuda®(lurasidone) tablets – retrospective reimbursement price adjustment for April 2024
Following representations made by Community Pharmacy England on behalf of community pharmacy contractors, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices for all strengths of Latuda® (lurasidone) tablets dispensed in April 2024. On 1 April 2024, there was an increase in the NHS list prices of Latuda® (all strengths) manufactured
Read more
- Community Pharmacy England News
- 7TH AUGUST 2024
- 0 COMMENTS
Medicine Supply Notification: Cefalexin 500mg tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Cefalexin 500mg tablets. MSN/2024/083 Tier 2 – medium impact Date of issue: 6th August 2024 Cefalexin 500mg tablets are out of stock until mid-September 2024. Cefalexin 500mg capsules remain available and can support an uplift in demand. Alternative cefalexin preparations remain
Read more
- Community Pharmacy England News

MHRA Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited)

Celebrating South Asian Heritage Month 2024

Community Pharmacy England makes submission to NHS review

MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited)

Rivaroxaban tablets – changes to reimbursement from September 2024

Community Pharmacy England presents strategy to improve outlook for pharmacy

Share your opinions on Pharmacy First thresholds: Pharmacy Owner Views Sought

MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd)

Latuda®(lurasidone) tablets – retrospective reimbursement price adjustment for April 2024

Medicine Supply Notification: Cefalexin 500mg tablets

Get in Touch

Working together with key healthcare stakeholders, local councils and other healthcare organisations as necessary to ensure that the provision of pharmaceutical services continues to be an integral part of Health and Social Care